Drug Database
Back to search

Finland· FI-REL-REL12531

Metalyse

A tenecteplase product containing tenecteplase, registered in Finland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 13 of our 19 countries.

ATC B01AD11

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedMetalyseATCB01AD11REGISTER NO.FI-REL-REL12531PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tenecteplaseAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tenecteplase is registered in 13 of 19 countries.

Countries holding a registration under ATC B01AD11 (tenecteplase), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose
Search tenecteplase products by name

Tenecteplase · ATC B01AD11

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tenecteplase costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tenecteplase · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • CZ Czechia$131.27
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Tenecteplase
Manufacturer
Boehringer Ingelheim International GmbH
Country
Finland (FI)
ATC code
B01AD11
ATC class
Tenecteplase
Defined daily dose
40 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    590919
    10000 U(50 mg)+10ml
    EUR 2757.05

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

143 interactions on record for tenecteplase.

Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tenecteplase against other medicinesHow interaction checks work

Tenecteplase · interactions on record

143 records

  • 49 severe
  • 94 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tenecteplase in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenecteplase products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Metalyse
  • Liechtenstein · Metalyse
  • Norway · Metalyse

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/46c8f443-cfa5-40de-821b-061837c55e3c
GET /v1/drugs/46c8f443-cfa5-40de-821b-061837c55e3c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "40",
  "form": "injektiokuiva-aine ja liuotin, liuosta varten",
  "route": "Laskimoon",
  "ddd_unit": "mg",
  "strength": "10000 U",
  "atc_label": "tenekteplaasi",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/00/169/006",
  "fimea_rel_id": "REL12531",
  "authorised_at": "2001-02-23"
}
API referenceMCP serverPlans

See everything about tenecteplase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console